We would like to thank the following sponsors for their support of the Justice Health Conference 2019.


Founding Sponsor
NHMRC Centre for Research Excellence in Offender Health

A: Justice Health Research Program, The Kirby Institute, Level 6, Wallace Wurth Building, UNSW Australia Sydney NSW 2052
T: +61 (02) 9385 9251
E: msimpson@kirby.unsw.edu.au
W: https://offenderhealth.net.au/ 

Prisoners have some of the worst health outcomes of any population group and are one of the most marginalised and stigmatised groups in Australia.  Each year more than 50,000 people cycle through Australian prisons, with the number of ex-prisoners in the community estimated to be around 400,000 nationally.  Due to lack of engagement with health services, many of these individuals enter the criminal justice system with pre-existing health conditions and most go undetected or untreated during incarceration.  Epidemiological studies have consistently shown rates of mental illness and bloodborne viral infections (e.g. hepatitis C and hepatitis B) to be much higher among prisoners than in the general population.  In addition to this, many engage in health risk behaviours such as injecting drug use, tobacco and other drug use at high levels.  Prisoners also show increased mortality particularly from drug overdose, suicide and violence.

The Australian Centre for Research Excellence (CRE) in Offender Health was funded by the Australian National Health and Medical Research Council in 2013.  Prior to this CRE, there was no national (or international) centre focused on offender health, despite the large discrepancies that exist between the overall health of prisoners and those in the general population.

The CRE in Offender Health brings together a team of internationally recognised researchers from across Australia who specialise in various aspects of offender health to advance research and policy in the area and to improve health outcomes for this population group.  The CRE prioritises two overall research themes – mental health and infectious diseases – both are in line with national priority areas and reflect the burden of diseases posed by these areas on the offender population.  The two primary themes fall under three research strands: Surveillance and monitoring, Treatment interventions and Evaluation.

Refreshment Break Sponsor - Tuesday 9 April
Department of Health

Tamsin Porter, Policy Officer

A: GPO Box 9848 Canberra ACT 2601

T: 02 6289 5834

E: tamsin.porter@health.gov.au

W: www.health.gov.au

Better health and wellbeing for all Australians, now and for future generations

Affiliation Sponsor

Matthew Squires, Business Development Manager

A: 5.04 15 Kensington Street, Kogarah NSW 2217

T: 02 8316 8930

E: matthew.squires@intrahealth.com

W: www.intrahealth.com.au

 Intrahealth is a global software and associated services company supplying world class solutions to the Australian healthcare market.

The underlying concept of the Intrahealth Solution is a world best-practice EMR, combined with a flexible Management System (PMS), able to function across multiple community-based practice types. Our customers range from Community & Mental Health Providers, GPs, Specialists, Network Care Providers (PHNs & LHDs) to Institutional providers such as Defence and Universities.

Because the Intrahealth Solution is readily adaptable to the unique multidisciplinary requirements of Justice Health, Intrahealth has rapidly expanded into partnerships with Correctional Services organisations such as Justice Health Victoria and WA Corrective Services.

Keynote Speaker Sponsor
Girra Maa Indigenous Health Discipline, Graduate School of Health, University of Technology Sydney
UTS horizontal logo.png

Dr Megan Williams, Senior Lecturer and Head of Discipline
A: Building 07, Level 04, 15 Broadway, Ultimo NSW 2007
T: 0400 073 358 and 02 9514 8000
E: Megan.Williams@uts.edu.au
W: https://www.uts.edu.au/about/graduate-school-health/indigenous-health

Girra Maa means ‘lively’ and ‘active’ in the language of the Wiradjuri people of central NSW.

Girra Maa supports Graduate School of Health staff and students to develop a lifelong commitment to respectful engagement with Indigenous peoples and to embed the Indigenous Graduate Attribute into curriculum. Girra Maa also conduct research with Aboriginal community parntners about health care accessibility and social and emotional wellbeing, funded by the NHMRC, ARC, Lowitja Institute, UTS and NSW Health. 

Professional Development Sponsor
Armchair Medical TV

Gary Smith, Director
A: Suite 1308, 109 Pitt Street Sydney NSW 2000
T: 02 9016 7116
E: gary@armchairmedical.tv
W: www.armchairmedical.tv

Armchair Medical TV is revolutionizing continuing medical education in Australia. It gives Health Care Providers almost unlimited choice in what, when and where they learn. Education providers can partner with Armchair Medical TV to greatly increase the impact of their educational events. Contact us at gary@armchairmedical.tv visit our website www.armchairmedical.tv or download the App from the App store.

The Mayi Kuwayi Study, National Centre for Epidemiology and Population Health, The Australian National University

Ray Lovett, Associate Professor and Program Leader
A: 54 Mills Road Acton ACT 2601
T: (02) 61256871
E: raymond.lovett@anu.edu.au
W: https://mkstudy.com.au/

The Mayi Kuwayu Study aims to understand how Aboriginal and Torres Strait Islander culture links to health and wellbeing. The Study has worked with many Aboriginal and Torres Strait Islander communities over the last three years to develop a survey about Aboriginal and Torres Strait Islander culture and wellbeing.

This Study will provide information for community, services and policy makers about things that improve Aboriginal and Torres Strait Islander health and wellbeing. We will share our findings so that Aboriginal and Torres Strait Islander communities throughout Australia.

The Mayi Kuwayu Study is available to all Aboriginal and Torres Strait Islanders 16 years and older.


Sarah Barnett, HCV Account Manager
A: Level 7, 241 O’Riordan Street, Mascot NSW 2020
T: 0481 910 275
E: sarah.barnett@abbvie.com
W: www.abbvie.com.au

As a new biopharmaceutical company, AbbVie combines the expertise of a recognised pharmaceutical company with the focus and innovative spirit of a biotech. Through a targeted, patient-centric approach to research and development, AbbVie accelerates new scientific discoveries to address some of the most complex diseases in the world, while our services and partnerships help us create greater access and outcomes for the health of all Australians. We focus on discovering, developing, and delivering medicines in therapeutic areas where we have proven expertise and where we can have an impact. These areas include: Immunology, Oncology, Virology and Neuroscience.

Contact Us: events@phaa.net.au 

© 2023 by Public Health Association of Australia.